Indeed, tumor-isolated CD103+ DCs, which were induced in the presence of Batf3, have a markedly higher efficiency in cross-presenting tumor antigens than other DC subsets, macrophages, monocytes, and neutrophils19. This evidence concerns the gene ITGAE and neoplasm.